;

Auto Summaries - Symptoms
Last updated: 2024 Oct 18
Total hit(s): 18851
S.No.
1
38626299
Enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in eastern China during the COVID-19 pandemic.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38787317
Regarding "Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic".
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38709953
Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
4
39393107
Poor stress resilience as an independent risk factor for severe COVID-19 and respiratory infections.
N/A
J Psychosom Res
2024 Oct 9
4.8
1
5
39360871
Letter Regarding: Long-Term Corneal Endothelial Parameters of COVID-19 Patients With Ocular Surface Symptoms.
N/A
Cornea
2024 Oct 3
2
1
6
39415603
Metabolic dysfunction-associated steatotic liver disease and BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant: correspondence.
N/A
J Gastroenterol Hepatol
2024 Oct 17
3.4
1
7
39401742
Risk of Acute Aortic Events Following COVID-19 and Influenza Respiratory Viral Infections: Comment.
N/A
Ann Vasc Surg
2024 Oct 12
1.18
1
8
39389773
Evidence for a Link of COVID-19-Associated Long-Term Neurologic Symptoms and Altered Brain Integrity?
N/A
AJNR Am J Neuroradiol
2024 Oct 10
3.38
1
9
39390426
Correction: COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia.
N/A
BMC Infect Dis
2024 Oct 10
2.58
1
10
39352650
Response to the Letter to the Editor Regarding "Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study".
N/A
Infect Dis Ther
2024 Oct 1
3.95
1
11
39389680
New Evidence for SARS-CoV-2 Vaccine Boosting in Patients With Chronic Lung Diseases.
N/A
Chest
2024 Oct
7.22
1
12
39229889
Methotrexate prolonged the shedding of replicable SARS-CoV-2 with re-increased antigens in a rheumatoid arthritis patient.
N/A
Scand J Rheumatol
2024 Sep 4
1
13
39329278
Updated consensus statement for China pulmonary rehabilitation of coronavirus disease 2019 (2023).
N/A
Chin Med J (Engl)
2024 Sep 27
1.053
1
14
39222140
Awake prone positioning for COVID-19 patients with acute respiratory failure: unknown appropriate duration.
N/A
Intensive Care Med
2024 Sep 2
8.61
1
15
39222134
Comparative efficacy of prolonged versus shorter awake prone positioning in managing acute respiratory failure in COVID-19 Patients. A Clinical Assessment.
N/A
Intensive Care Med
2024 Sep 2
8.61
1
16
39269353
[Molnupiravir reduces symptoms duration but does not decrease hospitalizations or deaths in vaccinated adults with Covid-19.].
N/A
Recenti Prog Med
2024 Sep
0.7
1
17
39269351
[Nirmatreolvir-ritonavir (Paxlovid) leads to no reduction of symptoms or hospitalizations in vaccinated or unvaccinated high-risk adults with Covid-19.].
N/A
Recenti Prog Med
2024 Sep
0.7
1
18
39112468
Structural basis for the interaction between human coronavirus HKU1 spike receptor binding domain and its receptor TMPRSS2.
N/A
Cell Discov
2024 Aug 8
4.65
1
19
39186127
Fugitive medical and patient-derived aerosol particle distribution following heparin nebulization in patients with COVID-19 acute hypoxemic respiratory failure: a secondary analysis of the CHARTER study.
N/A
Intensive Care Med Exp
2024 Aug 26
- n/a -
1
20
39183112
DNA methylation levels of the ACE2 promoter are not associated with symptoms-severity and related-disability in previously hospitalized COVID-19 survivors.
N/A
Eur J Intern Med
2024 Aug 24
3.05
1
21
39175408
Chronic cough, wheezing, and atelectasis following COVID-19: A case report on the diagnostic evaluation and effective treatment of a life-threatening asthma mimicker.
N/A
Pediatr Pulmonol
2024 Aug 23
2.64
1
22
39209599
Mitigated transmission and health impact of COVID-19 in Beijing, China during spring 2024: Comparison with the global trends.
N/A
Sci Bull (Beijing)
2024 Aug 22
5.08
1
23
39154330
[Symptoms and options in rehabilitation of post-COVID-19 syndrome (long-COVID)].
N/A
Orv Hetil
2024 Aug 18
0.8
1
24
39142213
Retraction notice to "Anxiety and depressive symptoms of German university students 20months after the COVID-19 outbreak - A cross-sectional study" [J. Affect. Disord. 320 (2023) 568 - 575].
N/A
J Affect Disord
2024 Aug 13
4.17
1
25
39100529
Higher Prevalence of Immunosuppression Among US Adults: Implications for Coronavirus Disease 2019 and Respiratory Pathogen Vaccinations.
N/A
Open Forum Infect Dis
2024 Aug
2.69
1